Range
- - -
Vol / Avg.
-/5K
Div / Yield
-
52 Wk
0.02 - 0.4
Mkt Cap
7.6M
Payout Ratio
-
Open
-
P/E
-
EPS
0
Shares
30.4M
Outstanding
-
Total Float
-
There is no Press for this Ticker
AngioGenex Inc is a United States-based biopharmaceutical company. It is dedicated to the development and commercialization of a novel, inexpensive treatment for vascular diseases including many forms of cancer and macular degeneration. Its lead drug candidates include AGX51 and several other proprietary small molecules that have shown specific activity in various animal models of various cancers and macular degeneration. Further, it also focuses on developing Id-inhibitor drugs to treat cancer and macular degeneration. Geographically, the activities are carried out through the region of the United States.

Related Companies

TickerCompanyChg %Mkt Cap
AGGXAngioGenex0%7.6M

AngioGenex Frequently Asked Questions

Q

How do I buy AngioGenex (AGGX) stock?

A

You can purchase shares of AngioGenex (OTC: AGGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are AngioGenex's (AGGX) competitors?

A

There are no as such competitors for AngioGenex.

Q

What is the target price for AngioGenex (AGGX) stock?

A

There is no analysis for AngioGenex

Q

Current Stock Price for AngioGenex (AGGX)?

A

The stock price for AngioGenex (OTC: AGGX) is $0.2502 last updated Mon Jul 26 2021 15:57:03 GMT+0000 (Coordinated Universal Time).

Q

Does AngioGenex (AGGX) pay a dividend?

A

There are no upcoming dividends for AngioGenex.

Q

When is AngioGenex (OTC:AGGX) reporting earnings?

A

AngioGenex does not have any upcoming earnings scheduled.

Q

Is AngioGenex (AGGX) going to split?

A

There is no upcoming split for AngioGenex.

Q

What sector and industry does AngioGenex (AGGX) operate in?

A

AngioGenex is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.